P361 Demystifying the NIH grant application process for international investigators

Abstract Poster session 3, September 23, 2022, 12:30 PM - 1:30 PM The National Institute of Allergy and Infectious Diseases (NIAID) funds one of the largest medical mycology research portfolios. The portfolio includes the major human fungal pathogens and covers basic fungal biology and the more translational areas of therapeutics, vaccines, and diagnostics. NIAID utilizes many granting mechanisms that are open to US and international researchers. These include investigator-initiated applications (R01, R21, and R03s) and targeted announcements for fungal research. Additionally, NIAID has a suite of preclinical services supporting therapeutic, diagnostic, and vaccine development. These services are free and available to investigators in academia, not-for-profit organizations, industry, or governments worldwide. The NIAID granting mechanism can be complicated. Tips and tricks for navigating the NIAID application process and preclinical services will be discussed.

Poster session 3, September 23, 2022, 12:30 PM -1:30 PM Background: Candida auris is an emerging multidrug-resistant pathogenic yeast. The increasing frequency of C. auris outbreaks is prompting alarm worldwide. This yeast survives and spreads on contaminated medical supplies, resulting in hospital outbreaks. To learn more about the yeast's spreading behaviors and transmission, we studied its persistence and survival on a variety of medical-related surfaces under diverse environmental conditions. Methods: A total of 104 CFU/mL solutions of four Candida species, including C. auris , C. albicans , C. parapsilosis , and C. glabrata , were inoculated onto different 2 × 2 cm sheets of cotton textile, polystyrene, paper, aluminum, glass, latex, and dried Sabouraud dextrose agar. Inoculated sheets were incubated at various temperatures and subjected to light and darkness at 1, 2, 7, 14, 30, 45, 60, and 120-day intervals. After culture of the sheets on Sabouraud dextrose agar plates, the viable CFUs of yeasts were counted.
Results: All four species remained alive on all surfaces for at least 1 week under ambient and refrigerator temperatures, darkness, and light exposure. However, only latex and polystyrene surfaces maintained viable C. auris and C.parapsilosis for a maximum of 30 days at ambient temperature and darkness. C. auris survived on dried Sabouraud dextrose agar sheets for ˃4 months.
Conclusions: Candida auris and other pathogenic yeasts can survive on a variety of medical surfaces for extended periods of time. Latex and polystyrene devices are the best medical matrices for yeast persistence. If C. auris has access to organic and nutritional components, its survival could be greatly increased. To prevent C. auris transmission, appropriate disinfection and decontamination methods should be considered.

Dona Love National Institutes of Health, Rockville, United States
Poster session 3, September 23, 2022, 12:30 PM -1:30 PM The National Institute of Allergy and Infectious Diseases ( NIAID ) funds one of the largest medical mycology research portfolios. The portfolio includes the major human fungal pathogens and covers basic fungal biology and the more translational areas of therapeutics, vaccines, and diagnostics. NIAID utilizes many granting mechanisms that are open to US and international researchers. These include investigator-initiated applications ( R01, R21, and R03s ) and targeted announcements for fungal research. Additionally, NIAID has a suite of preclinical services supporting therapeutic, diagnostic, and vaccine development. These services are free and available to investigators in academia, not-for-profit organizations, industry, or governments worldwide. The NIAID granting mechanism can be complicated. Tips and tricks for navigating the NIAID application process and preclinical services will be discussed.  Figure 2. Isolation rate of Aspergillus species was 35% in winters, 31% in post-monsoon, 25% in summers. Isolation rate of Penicillium species was 19% in post-monsoon, 16% in winter and 15% in summers. Maximum number of dematiaceous fungi were isolated in summer season with isolation rate of 30% in summers as compared with 21.5% in post-monsoon and 19% in winters. Few yeasts isolated were Rhodotorula, Trichosporon, and Ustilago . Mucorales isolated rarely included Rhizopus, Absidia, Syncephalastrum, and Mucor species. Fungal colony forming units in the water samples ranged from 50 to 450 colony forming units/liter of water.
Conclusion: The distribution of fungi in hospital water showed diversity and seasonal variability. Aspergillus species were isolated in maximum number in the winter season, Penicillium species in post-monsoon season and dematiaceous fungi in the winter season. Water as a source of fungal infection in critical care units, remains a relatively neglected area. Water supply could be a source of nosocomial fungal infections. Improving the quality of water by regular testing for fungal contamination and appropriate action to reduce its burden may reduce the hospital-acquired fungal infections.